Hori K - Search Results

1

Efficacy of Olanzapine in Addition to Standard Triplet Antiemetic Therapy for Cisplatin-Based Chemotherapy: A Secondary Analysis of the J-FORCE Randomized Clinical Trial.

Abe M, Yamaguchi T, Fujita Y, Nishimura T, Kitagawa K, Inui N, Hirano K, Sakata Y, Iihara H, Shibuya Y, Suzuki K, Shibata K, Hori K, Daga H, Nakayama T, Sakata Y, Takahashi TY, Zenda S, Hashimoto H. Abe M, et al. Among authors: hori k. JAMA Netw Open. 2023 May 1;6(5):e2310894. doi: 10.1001/jamanetworkopen.2023.10894. JAMA Netw Open. 2023. PMID: 37129897 Free PMC article. Clinical Trial.

2

[Clinical Application of Gemcitabine plus Cisplatin plus Bevacizumab Combination Chemotherapy for Ovarian Clear Cell Carcinoma].

Nakagawa M, Ito K, Uragami K, Suzuki J, Shiomi M, Ono H, Shimoji K, Yamashita M, Onoue M, Yoshioka E, Goto M, Tashima L, Hori K. Nakagawa M, et al. Among authors: hori k. Gan To Kagaku Ryoho. 2021 Mar;48(3):375-378. Gan To Kagaku Ryoho. 2021. PMID: 33790161 Japanese.

3

Adjuvant Chemotherapy for Endometrial Cancer (ACE) trial: A randomized phase II study for advanced endometrial carcinoma.

Egawa-Takata T, Ueda Y, Ito K, Hori K, Tadahiro S, Nagasawa T, Nishio S, Ushijima K, Koji N, Enomoto T, Kikuchi A, Honma S, Oishi T, Shimada M, Takei Y, Fujiwara H, Tanabe H, Okamoto A, Nishio Y, Yamada T, Kimura T. Egawa-Takata T, et al. Among authors: hori k. Cancer Sci. 2022 May;113(5):1693-1701. doi: 10.1111/cas.15310. Epub 2022 Mar 10. Cancer Sci. 2022. PMID: 35218673 Free PMC article. Clinical Trial.

4

[A Case of Pneumocystis Pneumonia during Chemotherapy for Recurrent Ovarian Cancer].

Shiomi M, Okubo R, Miyagi K, Murakami J, Kuwaduru T, Uragami K, Nakagawa M, Yoshioka E, Tsuruta T, Tashima R, Hori K, Ito K. Shiomi M, et al. Among authors: hori k. Gan To Kagaku Ryoho. 2015 Jul;42(7):879-81. Gan To Kagaku Ryoho. 2015. PMID: 26197755 Japanese.

5

Phase I study on pegylated liposomal doxorubicin in combination with docetaxel for patients with platinum-resistant or partially platinum-sensitive epithelial ovarian cancer: The Kansai Clinical Oncology Group study.

Hori K, Ito K, Kuritani K, Kuji S, Furukawa N, Tsubamoto H, Arakawa A. Hori K, et al. J Cancer Res Ther. 2019 Oct-Dec;15(6):1201-1206. doi: 10.4103/jcrt.JCRT_742_16. J Cancer Res Ther. 2019. PMID: 31898647 Free article. Clinical Trial.

6

Combination therapy of oral cyclophosphamide and bevacizumab for patients with recurrent ovarian and peritoneal cancer.

Goto M, Tsubamoto H, Isono-Taniguchi R, Takimoto Y, Tashima L, Hori K, Ito K. Goto M, et al. Among authors: hori k. Medicine (Baltimore). 2023 Feb 22;102(8):e32880. doi: 10.1097/MD.0000000000032880. Medicine (Baltimore). 2023. PMID: 36827071 Free PMC article.

7

[A Case of Bilateral Pneumothorax after Chemotherapy for Uterine Leiomyosarcoma with Multiple Lung Metastases].

Murakami J, Hori K, Okubo R, Miyagi K, Shiomi M, Uragami K, Nakagawa M, Yoshioka E, Tsuruta T, Tashima R, Ito K. Murakami J, et al. Among authors: hori k. Gan To Kagaku Ryoho. 2016 Feb;43(2):259-61. Gan To Kagaku Ryoho. 2016. PMID: 27067695 Japanese.

8

Effectiveness of intraperitoneal or intrapleural administration of triamcinolone acetonide for the control of malignant ascites and pleural effusion (Kansai Clinical Oncology Group-G1102 study).

Ito K, Tsubamoto H, Inoue K, Miyoshi Y, Ito Y, Hori K. Ito K, et al. Among authors: hori k. J Cancer Res Ther. 2017 Jul-Sep;13(3):446-450. doi: 10.4103/0973-1482.176426. J Cancer Res Ther. 2017. PMID: 28862207 Free article.

9

A phase II, open-labeled, single-arm study of dose-dense paclitaxel plus carboplatin in advanced or recurrent uterine endometrial cancer treatment: a KCOG-G1303, DOENCA trial.

Hori K, Nishio S, Ushijima K, Kasamatsu Y, Kondo E, Takehara K, Ito K. Hori K, et al. J Gynecol Oncol. 2021 Jul;32(4):e64. doi: 10.3802/jgo.2021.32.e64. J Gynecol Oncol. 2021. PMID: 34085798 Free PMC article. Clinical Trial.

10

Phase II study of gemcitabine, cisplatin, and bevacizumab for first recurrent and refractory ovarian clear cell carcinoma Kansai Clinical Oncology Group-G1601.

Ito K, Nakagawa M, Shimokawa M, Hori K, Tashima L, Goto M, Yanagida S, Suzuki J, Kaya R, Kawabata A, Yamada K, Park J, Nasu H, Nishio S, Kondo E, Kaneda M, Tsubamoto H, Arakawa A, Nagasawa T, Motohashi T. Ito K, et al. Among authors: hori k. Anticancer Drugs. 2023 Aug 1;34(7):857-865. doi: 10.1097/CAD.0000000000001472. Epub 2022 Dec 5. Anticancer Drugs. 2023. PMID: 36729915 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,536 results

Search Page

Filters